<DOC>
	<DOCNO>NCT01413139</DOCNO>
	<brief_summary>The objective clinical investigation evaluate puncture site complication rate well short- long-term ( 24 month ) outcome treatment mean Astron Pulsar / Astron Pulsar-18 stent implantation symptomatic ( Rutherford 2-4 ) femoro-popliteal arterial stenotic occlusive lesion , use 4F compatible device BIOTRONIK without use closure device . The hypothesis primary patency 12 month non-inferior primary patency obtain Durability study ( 72.2 % ) .</brief_summary>
	<brief_title>4-EVER : Trial Investigating Safety 4F Endovascular Treatment Infra-Inguinal Arterial Stenotic Disease</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>De novo , restenotic reoccluded lesion locate femoropopliteal artery suitable endovascular treatment Patient present score 2 4 accord Rutherford classification Patient willing comply specify followup evaluation predefined time interval time Patient &gt; 18 year old Patient understand nature procedure provide write informed consent , prior enrollment study Prior enrollment , target lesion cross standard guidewire manipulation Patient eligible treatment 4F compatible device Angiographic The target lesion locate within native superficial femoral artery : Distal point 3 cm knee joint 1 cm origin profunda femoralis . The target lesion angiographic evidence stenosis restenosis &gt; 50 % occlusion Length target lesion =20 cm visual estimation cover one stent Target vessel diameter visually estimate =4 mm =6.5 mm There angiographic evidence least onevesselrunoff foot Presence another stent target vessel place previous procedure Presence aortic thrombosis significant common femoral ipsilateral stenosis Previous bypass surgery limb Patients contraindicate antiplatelet therapy , anticoagulant thrombolytic Patients exhibit persistent acute intraluminal thrombus target lesion site Perforation angioplasty site evidence extravasation contrast medium Patients know hypersensitivity nickeltitanium Patients uncorrected bleed disorder Female patient child bear potential take adequate contraceptive currently breastfeed Life expectancy le 12 month Ipsilateral iliac artery treatment target lesion treatment residual stenosis &gt; 30 % Use thrombectomy , atherectomy laser device procedure Any planned surgical intervention/procedure 30 day study procedure Any patient consider hemodynamically unstable onset procedure Patient currently participate another investigational drug device study reach primary endpoint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>peripheral Vascular Disease</keyword>
	<keyword>claudication</keyword>
	<keyword>rest pain</keyword>
</DOC>